secwatch / observer
8-K filed January 6, 2025, 6:59 PM ET CIK 0001673772
leadership confidence high sentiment neutral materiality 0.30

RAPT Therapeutics appoints Lori Lyons-Williams as Board Chair; Rieflin resigns

RAPT Therapeutics, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Lori Lyons-Williams

Chair of the Board
RAPT Therapeutics, Inc.
Effective
2025-01-05
Filed
January 6, 2025, 6:59 PM ET
On January 5, 2025, the Board appointed Lori Lyons-Williams as Chair of the Board to succeed Mr. Rieflin.
Departed

William Rieflin

Director
RAPT Therapeutics, Inc.
Effective
2025-01-03
Successor
Lori Lyons-Williams
Filed
January 6, 2025, 6:59 PM ET
On January 3, 2025, William Rieflin resigned from the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lori Lyons-Williams was appointed as Chair of the Board at RAPT Therapeutics, Inc..

Action
appointed
Role
Chair of the Board
Exact text from the filing
On January 5, 2025, the Board appointed Lori Lyons-Williams as Chair of the Board to succeed Mr. Rieflin.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William Rieflin resigned as director at RAPT Therapeutics, Inc..

Action
resigned
Exact text from the filing
On January 3, 2025, William Rieflin resigned from the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”), effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0000950170-25-002193
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.